Latest Brain tumor Stories
VANCOUVER, British Columbia and MENLO PARK, Calif., March 2, 2015 /PRNewswire/ -- DelMar Pharmaceuticals,
New system for fast, precise radiotherapy and radiosurgery now ready for clinical use SINGAPORE, March 2, 2015 /PRNewswire/ -- Mount Elizabeth Novena Hospital will soon become the
Patient with Brain Tumor Received Extremely Precise Treatment in Reduced Time SUNNYVALE, Calif., March 2, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that
Cancer research has truly gone to the dogs as scientists at the University of Illinois have announced the start of phase I trials for a drug showed good results in the treatment of spontaneously occurring cancers in pet dogs.
Industry and Academic Leader Co-Founded Several Successful Biotechnology Companies, Including Alnylam, Cubist and Alkermes SAN DIEGO, Feb.
- Updated Phase I/II clinical trial data on the maximum tolerated dose for VAL-083 in the treatment of glioblastoma multiforme (GBM) to be presented - VANCOUVER, British Columbia
RnRMarketResearch.com adds “Oligodendroglioma – Pipeline Review, H2 2014” report to its store.
NEW YORK, Feb. 19, 2015 /PRNewswire/ -- Novogen presented yesterday (Wednesday February 18) to an audience of stockholders, analysts, investors and investment bankers.
University Of Miami Brain Tumor Initiative, The Miami Children's Hospital Brain Cancer Initiative and Local Heroes to be Honored for their Tireless Support and Ongoing Hope for a Cure MIAMI,
BETHESDA, Md., Feb. 19, 2015 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.